Evidence map›Paper›PMID 22878960›Full record

ArticleJournal of the American Society of Nephrology : JASN2012

Absence of MyD88 signaling induces donor-specific kidney allograft tolerance.

Huiling Wu, Gerda A Noordmans, Maya R O'Brien, Jin Ma, Cathy Y Zhao, Geoff Y Zhang, Tony K T Kwan, Stephen I Alexander, Steven J Chadban

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 57 citations in OpenAlex.

  1. Can mouse kidney transplant models inform mechanisms of injury and acceptance in clinical kidney transplantation?American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Review
  2. Review
  3. Review
  4. Review
  5. Methods to Study TLRs in Transplantation.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Aging and the immune response to organ transplantation.The Journal of clinical investigation · 2017
    Review
  16. Article
  17. Innate immune mechanisms in transplant allograft vasculopathy.Current opinion in organ transplantation · 2016
    Review
  18. Review
  19. Recipient Myd88 Deficiency Promotes Spontaneous Resolution of Kidney Allograft Rejection.Journal of the American Society of Nephrology : JASN · 2015
    Article
  20. How the Innate Immune System Senses Trouble and Causes Trouble.Clinical journal of the American Society of Nephrology : CJASN · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Huiling WuTransplant Research Group, University of Sydney, Sydney, NSW 2006, Australia. huiling.wu@sydney.edu.au
Gerda A Noordmans
Maya R O'Brien
Jin Ma
Cathy Y Zhao
Geoff Y Zhang
Tony K T Kwan
Stephen I Alexander
Steven J Chadban
Royal Prince Alfred Hospital · AUChildren's Hospital at Westmead · AUUniversity of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toll-like receptors (TLRs) play a fundamental role in innate immunity and provide a link between innate and adaptive responses to an allograft; however, whether the development of acute and chronic allograft rejection requires TLR signaling is unknown. Here, we studied TLR signaling in a fully MHC-mismatched, life-sustaining murine model of kidney allograft rejection. Mice deficient in the TLR adaptor protein MyD88 developed donor antigen-specific tolerance, which protected them from both acute and chronic allograft rejection and increased their survival after transplantation compared with wild-type controls. Administration of an anti-CD25 antibody to MyD88-deficient recipients depleted CD4(+)CD25(+)FoxP3(+) cells and broke tolerance. In addition, defective development of Th17 immune responses to alloantigen both in vitro and in vivo occurred, resulting in an increased ratio of Tregs to Th17 effectors. Thus, MyD88 deficiency was associated with an altered balance of Tregs over Th17 cells, promoting tolerance instead of rejection. This study provides evidence that targeting innate immunity may be a clinically relevant strategy to facilitate transplantation tolerance.

Indexed as

AnimalsCytokinesGraft RejectionGraft SurvivalHumansImmune ToleranceImmunity, InnateInterleukin-2 Receptor alpha SubunitIsoantigensKidney TransplantationLymphocyte Culture Test, MixedLymphocyte DepletionMaleMiceMice, Inbred BALB CMice, Inbred C57BLCytokinesInterleukin-2 Receptor alpha SubunitIsoantigensMyd88 protein, mouseMyeloid Differentiation Factor 88RNA, Messenger

Identifiers

PMID22878960
PMCPMC3458459
OpenAlexW2170999650

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.